IP Library Granted Patent US 8,241,658
Granted Patent B2
US 8,241,658 · App. 12/838,741 · Granted Aug 14, 2012

Prebiotic compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,241,658
App. No.
12/838,741
Granted
Aug 14, 2012
Kind
B2
Abstract

The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.

Claims (14)

1. A method of promoting the growth of Lactobacilli , the method comprising: administering to a mammal a composition comprising a) about 15 g to about 20 g of a fructo-oligosaccharide (FOS) and galacto-oligosaccharide (GOS) blend per 100 mL of composition; (b) each of said oligofructose and oligogalctose are composed of chains with a degree of polymerization ranging from about 2 to about 7; (c) the weight ratio of FOS and GOS is from about 0.5 to about 20; and (d) the FOS and GOS are capable of synergistically promoting the growth of Lactobacilli , such that their combined prebiotic property is greater than the sum of their individual prebiotic properties.

2. The method of claim 1 , wherein said mammal is a human.

3. The method of claim 1 , wherein said composition is a nutritional composition.

4. The method of claim 1 , wherein said composition is a nutritional composition for treating gastrointestinal disorders.

5. The method of claim 4 , wherein said gastrointestinal disorders is diarrhea.

6. The method of claim 4 , wherein said gastrointestinal disorders is constipation.

7. The method of claim 1 , wherein said composition is a nutritionally complete composition.

8. The method of claim 1 , wherein said composition is a low calorie nutritional composition.

9. The method of claim 1 , wherein said composition is a high calorie nutritional composition.

10. The method of claim 4 , wherein said treating is selected from the group consisting of maintaining the intestinal flora, restoring the intestinal flora, and combinations thereof.

11. The method of claim 4 , wherein said treating is treating a condition selected from the group consisting of inflammatory bowel disease, ulcerative colitis, Crohn's disease, and combinations thereof.

12. The method of claim 4 , wherein said treating is selected from the group consisting of stimulating the growth of bifidobacteria, stimulating the growth of lactobacilli , and combinations thereof.

13. The method of claim 4 , wherein said treating is inhibiting the growth of at least one of bacteroides , clostridia, coliforms, and sulphate reducing bacteria.

14. The method of claim 4 , wherein said treating is the treatment of infection by pathogenic gut bacteria.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →